Work

Panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2020

Authors: Eudocia Quant Lee, David A. Reardon, David Schiff, Jan Drappatz, Alona Muzikansky, Sean Aaron Grimm, Andrew David Norden, Lakshmi Nayak, Rameen Beroukhim, Mikael L. Rinne, Andrew S. Chi, Tracy Batchelor, Kelly Hempfling, Christine Sceppa McCluskey, Katrina H. Smith, Sarah C. Gaffey, Brendan Wrigley, Jeffrey J. Raizer, Patrick Y. Wen

Institutions: Dana-Farber Cancer Institute, University of Virginia Medical Center, University of Pittsburgh, Massachusetts General Hospital, Harvard University, Northwestern University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599208091

Cites:

Cited by: 3

Related to: 10